# OnCo record arsenal-bio (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/arsenal-bio/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "arsenal-bio" ;
  schema:name "Arsenal Biosciences"@en ;
  schema:description "Programmable CAR-T company using logic gates so cells fire only when two tumour proteins are present; AB-2100 (PSMA + CA9) is in phase 1/2 for kidney cancer."@en ;
  schema:url <https://onco.cc/companies/arsenal-bio/>, <https://arsenalbio.com> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06245915>, <https://www.parkerici.org/?s=arsenalbio> ;
  onco:tag "frontier" ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/rcc/>, <https://onco.cc/cancers/ovarian/> ;
  onco:sections <https://onco.cc/fronts/cell-therapy/> ;
  onco:technologies <https://onco.cc/technologies/armored-car/>, <https://onco.cc/technologies/car-t/> ;
  onco:targets <https://onco.cc/targets/psma/> ;
  onco:companies <https://onco.cc/companies/bms/>, <https://onco.cc/companies/regeneron/> ;
  onco:institutions <https://onco.cc/institutions/parker-institute/> ;
  onco:trials <https://onco.cc/trials/nct06245915/>, <https://onco.cc/trials/nct07285694/> .